These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 31087627)

  • 21. Sirolimus for the treatment of progressive kaposiform hemangioendothelioma: A multicenter retrospective study.
    Ji Y; Chen S; Xiang B; Li K; Xu Z; Yao W; Lu G; Liu X; Xia C; Wang Q; Li Y; Wang C; Yang K; Yang G; Tang X; Xu T; Wu H
    Int J Cancer; 2017 Aug; 141(4):848-855. PubMed ID: 28486787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon: successful treatment with vincristine and ticlopidine.
    Barabash-Neila R; García-Rodríguez E; Bernabeu-Wittel J; Bueno-Rodríguez I; Ramírez-Villar G; López-Gutierrez JC
    Indian J Pediatr; 2012 Oct; 79(10):1386-7. PubMed ID: 22161581
    [No Abstract]   [Full Text] [Related]  

  • 23.
    Russell TB; Rinker EK; Dillingham CS; Givner LB; McLean TW
    Pediatrics; 2018 Apr; 141(Suppl 5):S421-S424. PubMed ID: 29610164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kaposiform haemangioendothelioma in an adult: lack of response to topical sirolimus and response to radiotherapy.
    Der Sarkissian SA; Wong XL; Kossard S; Hong A; Sebaratnam DF
    Clin Exp Dermatol; 2022 Jan; 47(1):192-193. PubMed ID: 34480811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kaposiform hemangioendothelioma and tufted angioma: two entities of the same clinicopathological spectrum.
    Nieto-Benito LM; Huerta-Aragonés J; Parra-Blanco V; Campos-Domínguez M
    An Bras Dermatol; 2023; 98(3):391-394. PubMed ID: 36604299
    [No Abstract]   [Full Text] [Related]  

  • 26. Association between extremity kaposiform hemangioendothelioma and lymphedema.
    Konczyk DJ; Goss JA; Maclellan RA; Greene AK
    Pediatr Dermatol; 2018 Jan; 35(1):e92-e93. PubMed ID: 29266383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of Kasabach-Merritt phenomenon following vaccination: More than a coincidence?
    Ji Y; Chen S; Yang K; Xia C; Peng S
    J Dermatol; 2018 Oct; 45(10):1203-1206. PubMed ID: 30118141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A case of kaposiform haemangioendothelioma successfully and safely treated with sirolimus.
    Wlodek C; Burt H; Shaw L
    Clin Exp Dermatol; 2017 Oct; 42(7):825-827. PubMed ID: 28703334
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of kaposiform hemangioendothelioma and tufted angioma.
    Liu XH; Li JY; Qu XH; Yan WL; Zhang L; Yang C; Zheng JW
    Int J Cancer; 2016 Oct; 139(7):1658-66. PubMed ID: 27252149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medical management of tumors associated with Kasabach-Merritt phenomenon: an expert survey.
    Tlougan BE; Lee MT; Drolet BA; Frieden IJ; Adams DM; Garzon MC
    J Pediatr Hematol Oncol; 2013 Nov; 35(8):618-22. PubMed ID: 23774156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NEWBORNS WITH KASABACH-MERRITT PHENOMENON-ASSOCIATED KAPOSIFORM HEMANGIOENDOTHELIOMA: A REPORT OF 6 CASES.
    Benzar IM; Rebenkov SO; Levytskyi AF; Fedoniuk LY; Fomina LV; Sas LM; Stravskyy TY
    Wiad Lek; 2020; 73(8):1785-1789. PubMed ID: 33055352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sirolimus therapy for kaposiform hemangioendothelioma with long-term follow-up.
    Wang Z; Yao W; Sun H; Dong K; Ma Y; Chen L; Zheng S; Li K
    J Dermatol; 2019 Nov; 46(11):956-961. PubMed ID: 31489702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful treatment of Kasabach-Merritt syndrome arising from kaposiform hemangioendothelioma by systemic corticosteroid therapy and surgery.
    Jiang RS; Hu R
    Int J Clin Oncol; 2012 Oct; 17(5):512-6. PubMed ID: 21947597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful Everolimus Treatment of Kaposiform Hemangioendothelioma With Kasabach-Merritt Phenomenon: Clinical Efficacy and Adverse Effects of mTOR Inhibitor Therapy.
    Matsumoto H; Ozeki M; Hori T; Kanda K; Kawamoto N; Nagano A; Azuma E; Miyazaki T; Fukao T
    J Pediatr Hematol Oncol; 2016 Nov; 38(8):e322-e325. PubMed ID: 26907642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pneumocystis jirovecii pneumonia: A potential complication of sirolimus therapy.
    Shetty AK
    J Paediatr Child Health; 2019 Apr; 55(4):484. PubMed ID: 30957331
    [No Abstract]   [Full Text] [Related]  

  • 36. Anesthestic management of Kassabach-Meritt Phenomenon in an adult: case report.
    Elkoundi A; Samali M; Kartite N; Tbouda M; Bensghir M; Haimeur C
    BMC Anesthesiol; 2016 Nov; 16(1):109. PubMed ID: 27829366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successful treatment of kaposiform lymphangiomatosis with sirolimus.
    Wang Z; Li K; Yao W; Dong K; Xiao X; Zheng S
    Pediatr Blood Cancer; 2015 Jul; 62(7):1291-3. PubMed ID: 25598153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of topical sirolimus on superficial Kaposiform haemangioendothelioma.
    Liu YX; Zhang J; Nie XL; Chen YL; Wang ZY; Xu ZG
    Australas J Dermatol; 2021 May; 62(2):e329-e331. PubMed ID: 33216947
    [No Abstract]   [Full Text] [Related]  

  • 39. Vascular Tumors in Infants: Case Report and Review of Clinical, Histopathologic, and Immunohistochemical Characteristics of Infantile Hemangioma, Pyogenic Granuloma, Noninvoluting Congenital Hemangioma, Tufted Angioma, and Kaposiform Hemangioendothelioma.
    Johnson EF; Davis DM; Tollefson MM; Fritchie K; Gibson LE
    Am J Dermatopathol; 2018 Apr; 40(4):231-239. PubMed ID: 29561329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased vascularization of retroperitoneal kaposiform hemangioendothelioma induced by treatment with sirolimus explains relief of symptoms.
    Iacobas I; Simon ML; Amir T; Gribbin CE; McPartland TG; Kaufman MR; Calderwood S; Nosher JL
    Clin Imaging; 2015; 39(3):529-32. PubMed ID: 25662209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.